Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Durham

Showing results (121-130 of 183) with videos related to

Pageof 19
Sort By:
The Journal of Allergy and Clinical Immunology|May 16, 2012
Allergen specificity of IgG(4)-expressing B cells in patients with grass pollen allergy undergoing immunotherapyLouisa K James, Holly Bowen, Rosaleen A Calvert, et al.
European Journal of Immunology|April 3, 2003
Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cellsSophia N Karagiannis, Qin Wang, Nick East, et al.
The Journal of Allergy and Clinical Immunology|December 6, 2003
The CX3C chemokine fractalkine in allergic asthma and rhinitisAnne-Cécile Rimaniol, Stephen J Till, Gilles Garcia, et al.
The Journal of Allergy and Clinical Immunology|February 2, 2011
Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodiesLouisa K James, Mohamed H Shamji, Samantha M Walker, et al.
The Journal of Allergy and Clinical Immunology|January 31, 2012
SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trialStephen R Durham, Waltraud Emminger, Alexander Kapp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 27, 2013
A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotypeKatharina Marth, Isabella Breyer, Margarete Focke-Tejkl, et al.
Clinical and Translational Allergy|December 19, 2015
Protocol for a randomised, double-blind, placebo-controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomesEsther Helen Steveling, Mongkol Lao-Araya, Christopher Koulias, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 27, 2022
Effects of Exercise and Sleep Deprivation on Reaction Severity During Oral Peanut Challenge: A Randomized Controlled TrialShelley Dua, Monica Ruiz-Garcia, Simon Bond, et al.
The Journal of Clinical Investigation|November 19, 2009
Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodelingStefanie Eyerich, Kilian Eyerich, Davide Pennino, et al.
The European Respiratory Journal|November 9, 2016
Omalizumab reduces bronchial mucosal IgE and improves lung function in non-atopic asthmaPrathap Pillai, Yih-Chih Chan, Shih-Ying Wu, et al.
Pageof 19

Showing results (121-130 of 183) with videos related to

Sort By:
Pageof 19
The Journal of Allergy and Clinical Immunology|May 16, 2012
Allergen specificity of IgG(4)-expressing B cells in patients with grass pollen allergy undergoing immunotherapyLouisa K James, Holly Bowen, Rosaleen A Calvert, et al.
European Journal of Immunology|April 3, 2003
Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cellsSophia N Karagiannis, Qin Wang, Nick East, et al.
The Journal of Allergy and Clinical Immunology|December 6, 2003
The CX3C chemokine fractalkine in allergic asthma and rhinitisAnne-Cécile Rimaniol, Stephen J Till, Gilles Garcia, et al.
The Journal of Allergy and Clinical Immunology|February 2, 2011
Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodiesLouisa K James, Mohamed H Shamji, Samantha M Walker, et al.
The Journal of Allergy and Clinical Immunology|January 31, 2012
SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trialStephen R Durham, Waltraud Emminger, Alexander Kapp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 27, 2013
A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotypeKatharina Marth, Isabella Breyer, Margarete Focke-Tejkl, et al.
Clinical and Translational Allergy|December 19, 2015
Protocol for a randomised, double-blind, placebo-controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomesEsther Helen Steveling, Mongkol Lao-Araya, Christopher Koulias, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 27, 2022
Effects of Exercise and Sleep Deprivation on Reaction Severity During Oral Peanut Challenge: A Randomized Controlled TrialShelley Dua, Monica Ruiz-Garcia, Simon Bond, et al.
The Journal of Clinical Investigation|November 19, 2009
Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodelingStefanie Eyerich, Kilian Eyerich, Davide Pennino, et al.
The European Respiratory Journal|November 9, 2016
Omalizumab reduces bronchial mucosal IgE and improves lung function in non-atopic asthmaPrathap Pillai, Yih-Chih Chan, Shih-Ying Wu, et al.
Pageof 19